Omalizumab therapy of bullous pemphigoid

Br J Dermatol. 2024 Jan 23;190(2):142-143. doi: 10.1093/bjd/ljad432.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-Allergic Agents* / therapeutic use
  • Humans
  • Immunoglobulin E
  • Omalizumab / therapeutic use
  • Pemphigoid, Bullous* / drug therapy
  • Retrospective Studies

Substances

  • Omalizumab
  • Anti-Allergic Agents
  • Immunoglobulin E